Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by AlwaysHighon Aug 15, 2019 9:01am
63 Views
Post# 30030864

RE:RE:RE:How is Canopy's revenue lower than last quarter. They say

RE:RE:RE:How is Canopy's revenue lower than last quarter. They say
DSEEGS wrote:
AlwaysHigh wrote:
I just read that CGC's oil/softgel revenue for Q1 was only $0.2 million compared to $36.5 million from the previous quarter. I told you months ago that their oils/softgels were very expensive compared to competitors and that people wouldn't pay that price but you told me I didn't know what I was talking about. Unless they continue to lower their prices of oils/softgels to be more in line with competitors (which they've already started to do), the bloodbath WILL continue. Ignore me if you want, and I'll see you again in 3 months. :-)



Let me get this straight . So you think that from one quarter to the next their sales in soft gels dropped 36.3 million because they are too expensive . try again


No, I think they dropped because there is NO demand for them and dispensaries aren't buying them because they can't even sell the ones they already have. Once again you want to be angry at me for simply telling you the truth. They are TOO expensive! Feel free to disagree/be angry with me but MARK MY WORDS, their pricing for oils/softgels is an issue. I'm a long time medical and recreational user in Canada, I know what I'm talking about...
Bullboard Posts